fda bpc-157 ineligible for compounding 503a 503b The is taking a hard look at peptides, and a decision happening right now could change how easily patients can get them. An FDA advisory committee is wrapping up meetings and FDA's Overreach on Compounded Peptides

FDA has identified BPC-157 among substances considered in the context of bulk drug substances used in compounding, citing concerns that include potential immunogenicity risks, peptide-related impurities, and incomplete active-material characterizationunderscoring the need to avoid consumer-use, clinical-use, or self-administration interpretation

How to Read the COA A certificate of analysis should refer to the exact batch being supplied

Pharmacokinetic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers"

Safety and Medical Guidance While improving your gut health is a positive step, it is important to be aware of "red flag" symptoms

What is Vitamin B12 and Why is it Important